Cargando…
HMGB3 is a potential diagnostic marker for early cervical lesion screening
Autores principales: | Cui, Qianwen, Zhao, Jiarong, Deng, Qingmei, Liu, Yu, Fu, Changfang, Wu, Qiang, Sun, Qiuyan, Weng, Haiyan, Dai, Haiming, Yang, Wulin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Chongqing Medical University
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10404999/ https://www.ncbi.nlm.nih.gov/pubmed/37554211 http://dx.doi.org/10.1016/j.gendis.2023.02.033 |
Ejemplares similares
-
The Tumorigenic Effect of the High Expression of Ladinin-1 in Lung Adenocarcinoma and Its Potential as a Therapeutic Target
por: Hu, Lei, et al.
Publicado: (2023) -
An Immune-Associated Genomic Signature Effectively Predicts Pathologic Complete Response to Neoadjuvant Paclitaxel and Anthracycline-Based Chemotherapy in Breast Cancer
por: Fu, Changfang, et al.
Publicado: (2021) -
Pan-cancer analysis reveals the associations between MMP13 high expression and carcinogenesis and its value as a serum diagnostic marker
por: Zhang, Xinhui, et al.
Publicado: (2023) -
HMGB1 released from GSDME-mediated pyroptotic epithelial cells participates in the tumorigenesis of colitis-associated colorectal cancer through the ERK1/2 pathway
por: Tan, Gao, et al.
Publicado: (2020) -
Critical diagnostic and cancer stem cell markers in neoplastic cells from canine primary and xenografted pulmonary adenocarcinoma
por: Tangchang, Warisraporn, et al.
Publicado: (2022)